BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00929851
Recruitment Status : Completed
First Posted : June 30, 2009
Last Update Posted : March 30, 2017
Information provided by (Responsible Party):
Chiesi Farmaceutici S.p.A.